Medtronic has recalled more than 204,000 devices used to assist hospital and other patients with end-stage heart failure due to the potential for power source interruptions, the Food and Drug Administration reported Friday. The HeartWare Ventricular Assist Device is used as a bridge to cardiac transplantation in patients who are at risk of death from end-stage left ventricular heart failure. Health care professionals and consumers may report adverse reactions and quality problems with the devices to the FDA’s MedWatch program. For more information, see the recent Medtronic letter to health care providers.

Related News Articles

Headline
In this “Safety Speaks” conversation, CommonSpirit Health's Beth Miller, system director, patient safety-performance improvement, and Austin Peterson, system…
Headline
In this conversation, Oren Guttman, M.D., anesthesiologist and vice president of High Reliability & Patient Safety at Thomas Jefferson University,…
Headline
A new AHA case study highlights how Springfield Memorial Hospital in Illinois revised its patient safety culture through the implementation of its unique,…
Chairperson's File
In this episode, I talk with Steve Diaz, M.D., chief medical officer at MaineGeneral Health in Augusta and an AHA board member. Steve is an emergency medicine…
Headline
The AHA Sept. 26 launched a new video series in which former AHA Board Chair Mindy Estes, M.D., has conversations with hospital and health system leaders about…
Perspective
There will always be administrative costs associated with operating a hospital. But the lion’s share of a hospital’s resources should be devoted to doing what…